JOURNAL OF IMMUNOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=576459, encodeId=41fb5e64596e, content=一审小修，修回后多久会给消息？已经两周了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576268, encodeId=5b995e626845, content=一个月晴墨 2019-09-05 00:00:00 发表: 你一审多久？, beContent=晴墨 2019-09-05 00:00:00 发表: 你一审多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Fri Sep 13 00:00:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575894, encodeId=02245e58941f, content=你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc2540158, createdName=晴墨, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575809, encodeId=ec1d5e5809c1, content=小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569153, encodeId=3bcf56915371, content=大修完，二审一般多久，拒的可能性大不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c16f1640069, createdName=放开和放, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567526, encodeId=ee0b56e526c3, content=publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567525, encodeId=6c6d56e52560, content=你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564232, encodeId=b1d0564232d2, content=请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表: 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, beContent=adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/08/d21d7d20bf4243c7c8213ee2b0107192.jpg, createdBy=940a2356363, createdName=飘飘然, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564110, encodeId=29d156411011, content=under review 36天了，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cdd1681338, createdName=kikishaw, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555425, encodeId=619e555425e5, content=JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Apr 26 15:08:00 CST 2018, time=2018-04-26, status=1, ipAttribution=)]

2019-09-17 1253095392_18685667

一审小修，修回后多久会给消息？已经两周了……

81 0

[GetPortalCommentsPageByObjectIdResponse(id=576459, encodeId=41fb5e64596e, content=一审小修，修回后多久会给消息？已经两周了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576268, encodeId=5b995e626845, content=一个月晴墨 2019-09-05 00:00:00 发表: 你一审多久？, beContent=晴墨 2019-09-05 00:00:00 发表: 你一审多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Fri Sep 13 00:00:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575894, encodeId=02245e58941f, content=你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc2540158, createdName=晴墨, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575809, encodeId=ec1d5e5809c1, content=小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569153, encodeId=3bcf56915371, content=大修完，二审一般多久，拒的可能性大不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c16f1640069, createdName=放开和放, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567526, encodeId=ee0b56e526c3, content=publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567525, encodeId=6c6d56e52560, content=你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564232, encodeId=b1d0564232d2, content=请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表: 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, beContent=adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/08/d21d7d20bf4243c7c8213ee2b0107192.jpg, createdBy=940a2356363, createdName=飘飘然, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564110, encodeId=29d156411011, content=under review 36天了，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cdd1681338, createdName=kikishaw, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555425, encodeId=619e555425e5, content=JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Apr 26 15:08:00 CST 2018, time=2018-04-26, status=1, ipAttribution=)]

2019-09-13 1253095392_18685667

一个月晴墨 2019-09-05 00:00:00 发表:
你一审多久？

晴墨 2019-09-05 00:00:00 发表: 你一审多久？

82 0

[GetPortalCommentsPageByObjectIdResponse(id=576459, encodeId=41fb5e64596e, content=一审小修，修回后多久会给消息？已经两周了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576268, encodeId=5b995e626845, content=一个月晴墨 2019-09-05 00:00:00 发表: 你一审多久？, beContent=晴墨 2019-09-05 00:00:00 发表: 你一审多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Fri Sep 13 00:00:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575894, encodeId=02245e58941f, content=你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc2540158, createdName=晴墨, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575809, encodeId=ec1d5e5809c1, content=小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569153, encodeId=3bcf56915371, content=大修完，二审一般多久，拒的可能性大不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c16f1640069, createdName=放开和放, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567526, encodeId=ee0b56e526c3, content=publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567525, encodeId=6c6d56e52560, content=你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564232, encodeId=b1d0564232d2, content=请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表: 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, beContent=adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/08/d21d7d20bf4243c7c8213ee2b0107192.jpg, createdBy=940a2356363, createdName=飘飘然, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564110, encodeId=29d156411011, content=under review 36天了，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cdd1681338, createdName=kikishaw, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555425, encodeId=619e555425e5, content=JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Apr 26 15:08:00 CST 2018, time=2018-04-26, status=1, ipAttribution=)]

2019-09-05 晴墨

你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表:
小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？

1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？

135 0

[GetPortalCommentsPageByObjectIdResponse(id=576459, encodeId=41fb5e64596e, content=一审小修，修回后多久会给消息？已经两周了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576268, encodeId=5b995e626845, content=一个月晴墨 2019-09-05 00:00:00 发表: 你一审多久？, beContent=晴墨 2019-09-05 00:00:00 发表: 你一审多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Fri Sep 13 00:00:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575894, encodeId=02245e58941f, content=你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc2540158, createdName=晴墨, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575809, encodeId=ec1d5e5809c1, content=小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569153, encodeId=3bcf56915371, content=大修完，二审一般多久，拒的可能性大不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c16f1640069, createdName=放开和放, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567526, encodeId=ee0b56e526c3, content=publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567525, encodeId=6c6d56e52560, content=你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564232, encodeId=b1d0564232d2, content=请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表: 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, beContent=adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/08/d21d7d20bf4243c7c8213ee2b0107192.jpg, createdBy=940a2356363, createdName=飘飘然, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564110, encodeId=29d156411011, content=under review 36天了，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cdd1681338, createdName=kikishaw, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555425, encodeId=619e555425e5, content=JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Apr 26 15:08:00 CST 2018, time=2018-04-26, status=1, ipAttribution=)]

2019-09-04 1253095392_18685667

小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？

85 0

[GetPortalCommentsPageByObjectIdResponse(id=576459, encodeId=41fb5e64596e, content=一审小修，修回后多久会给消息？已经两周了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576268, encodeId=5b995e626845, content=一个月晴墨 2019-09-05 00:00:00 发表: 你一审多久？, beContent=晴墨 2019-09-05 00:00:00 发表: 你一审多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Fri Sep 13 00:00:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575894, encodeId=02245e58941f, content=你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc2540158, createdName=晴墨, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575809, encodeId=ec1d5e5809c1, content=小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569153, encodeId=3bcf56915371, content=大修完，二审一般多久，拒的可能性大不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c16f1640069, createdName=放开和放, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567526, encodeId=ee0b56e526c3, content=publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567525, encodeId=6c6d56e52560, content=你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564232, encodeId=b1d0564232d2, content=请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表: 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, beContent=adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/08/d21d7d20bf4243c7c8213ee2b0107192.jpg, createdBy=940a2356363, createdName=飘飘然, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564110, encodeId=29d156411011, content=under review 36天了，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cdd1681338, createdName=kikishaw, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555425, encodeId=619e555425e5, content=JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Apr 26 15:08:00 CST 2018, time=2018-04-26, status=1, ipAttribution=)]

2019-04-05 放开和放

大修完，二审一般多久，拒的可能性大不？

138 0

[GetPortalCommentsPageByObjectIdResponse(id=576459, encodeId=41fb5e64596e, content=一审小修，修回后多久会给消息？已经两周了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576268, encodeId=5b995e626845, content=一个月晴墨 2019-09-05 00:00:00 发表: 你一审多久？, beContent=晴墨 2019-09-05 00:00:00 发表: 你一审多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Fri Sep 13 00:00:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575894, encodeId=02245e58941f, content=你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc2540158, createdName=晴墨, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575809, encodeId=ec1d5e5809c1, content=小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569153, encodeId=3bcf56915371, content=大修完，二审一般多久，拒的可能性大不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c16f1640069, createdName=放开和放, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567526, encodeId=ee0b56e526c3, content=publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567525, encodeId=6c6d56e52560, content=你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564232, encodeId=b1d0564232d2, content=请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表: 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, beContent=adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/08/d21d7d20bf4243c7c8213ee2b0107192.jpg, createdBy=940a2356363, createdName=飘飘然, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564110, encodeId=29d156411011, content=under review 36天了，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cdd1681338, createdName=kikishaw, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555425, encodeId=619e555425e5, content=JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Apr 26 15:08:00 CST 2018, time=2018-04-26, status=1, ipAttribution=)]

2019-03-03 Jason Chan

publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表:
JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点.

bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点.

101 0

[GetPortalCommentsPageByObjectIdResponse(id=576459, encodeId=41fb5e64596e, content=一审小修，修回后多久会给消息？已经两周了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576268, encodeId=5b995e626845, content=一个月晴墨 2019-09-05 00:00:00 发表: 你一审多久？, beContent=晴墨 2019-09-05 00:00:00 发表: 你一审多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Fri Sep 13 00:00:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575894, encodeId=02245e58941f, content=你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc2540158, createdName=晴墨, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575809, encodeId=ec1d5e5809c1, content=小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569153, encodeId=3bcf56915371, content=大修完，二审一般多久，拒的可能性大不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c16f1640069, createdName=放开和放, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567526, encodeId=ee0b56e526c3, content=publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567525, encodeId=6c6d56e52560, content=你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564232, encodeId=b1d0564232d2, content=请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表: 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, beContent=adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/08/d21d7d20bf4243c7c8213ee2b0107192.jpg, createdBy=940a2356363, createdName=飘飘然, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564110, encodeId=29d156411011, content=under review 36天了，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cdd1681338, createdName=kikishaw, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555425, encodeId=619e555425e5, content=JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Apr 26 15:08:00 CST 2018, time=2018-04-26, status=1, ipAttribution=)]

2019-03-03 Jason Chan

你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢

139 0

[GetPortalCommentsPageByObjectIdResponse(id=576459, encodeId=41fb5e64596e, content=一审小修，修回后多久会给消息？已经两周了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576268, encodeId=5b995e626845, content=一个月晴墨 2019-09-05 00:00:00 发表: 你一审多久？, beContent=晴墨 2019-09-05 00:00:00 发表: 你一审多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Fri Sep 13 00:00:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575894, encodeId=02245e58941f, content=你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc2540158, createdName=晴墨, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575809, encodeId=ec1d5e5809c1, content=小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569153, encodeId=3bcf56915371, content=大修完，二审一般多久，拒的可能性大不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c16f1640069, createdName=放开和放, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567526, encodeId=ee0b56e526c3, content=publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567525, encodeId=6c6d56e52560, content=你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564232, encodeId=b1d0564232d2, content=请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表: 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, beContent=adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/08/d21d7d20bf4243c7c8213ee2b0107192.jpg, createdBy=940a2356363, createdName=飘飘然, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564110, encodeId=29d156411011, content=under review 36天了，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cdd1681338, createdName=kikishaw, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555425, encodeId=619e555425e5, content=JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Apr 26 15:08:00 CST 2018, time=2018-04-26, status=1, ipAttribution=)]

2018-12-09 飘飘然

请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表::
SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表:
请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待

adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待

120 0

[GetPortalCommentsPageByObjectIdResponse(id=576459, encodeId=41fb5e64596e, content=一审小修，修回后多久会给消息？已经两周了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576268, encodeId=5b995e626845, content=一个月晴墨 2019-09-05 00:00:00 发表: 你一审多久？, beContent=晴墨 2019-09-05 00:00:00 发表: 你一审多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Fri Sep 13 00:00:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575894, encodeId=02245e58941f, content=你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc2540158, createdName=晴墨, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575809, encodeId=ec1d5e5809c1, content=小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569153, encodeId=3bcf56915371, content=大修完，二审一般多久，拒的可能性大不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c16f1640069, createdName=放开和放, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567526, encodeId=ee0b56e526c3, content=publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567525, encodeId=6c6d56e52560, content=你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564232, encodeId=b1d0564232d2, content=请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表: 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, beContent=adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/08/d21d7d20bf4243c7c8213ee2b0107192.jpg, createdBy=940a2356363, createdName=飘飘然, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564110, encodeId=29d156411011, content=under review 36天了，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cdd1681338, createdName=kikishaw, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555425, encodeId=619e555425e5, content=JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Apr 26 15:08:00 CST 2018, time=2018-04-26, status=1, ipAttribution=)]

2018-12-06 kikishaw

under review 36天了，着急

134 0

[GetPortalCommentsPageByObjectIdResponse(id=576459, encodeId=41fb5e64596e, content=一审小修，修回后多久会给消息？已经两周了……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Tue Sep 17 00:00:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576268, encodeId=5b995e626845, content=一个月晴墨 2019-09-05 00:00:00 发表: 你一审多久？, beContent=晴墨 2019-09-05 00:00:00 发表: 你一审多久？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Fri Sep 13 00:00:00 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575894, encodeId=02245e58941f, content=你一审多久？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58bc2540158, createdName=晴墨, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575809, encodeId=ec1d5e5809c1, content=小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/186fa0154c5a60f264db4f5e2054307b.jpg, createdBy=3ce42571156, createdName=1253095392_18685667, createdTime=Wed Sep 04 00:00:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569153, encodeId=3bcf56915371, content=大修完，二审一般多久，拒的可能性大不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c16f1640069, createdName=放开和放, createdTime=Fri Apr 05 00:00:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567526, encodeId=ee0b56e526c3, content=publicationinJBC.Beforefinalacceptance,however,yourmanuscriptwillgothroughtwoqualitycontrolchecks.?First,thefiguresinyourmanuscriptwillbereviewedforqualityandadherencetoeditorialpolicies.YoumaybecontactedbyoneofourImageAnalystsforadditionalinformation,sourcefiles,orbetter-qualityimagefiles.Additionally,youmayberequestedtoreviseyourfiguressuchthattheyareofsufficientresolutionandqualityforpublication.Theserevisionsmayincludeadjustingbrightness/contrast,indicatingsplicesites,includingmolecularweightmarkers,andimprovingfigureresolution.?Inthesecondcheck,ourEditorialAssistantswillcheckthatyourmanuscriptisformattedproperly,themetadataassociatedwithyourarticleiscorrect,andanydatasetsassociatedwithyourarticlearereleased.Theymaycontactyoutoreviseyoursubmissionorreleaseyourdatasets.Pleasenotethatfinalacceptanceofyourmanuscriptiscontingentuponbothofthesereviews.Ifyouareunabletocomplywiththeirrequests,yourmanuscriptmaybesentbacktoyouforanotherroundofeditorialpeerreview.bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=bigapple001 2018-04-26 15:08:00 发表: JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567525, encodeId=6c6d56e52560, content=你好，打扰一下，JBC修回稿，编辑通知tentativelyaccepted,但是需要finalqualitycontrol，邮件如下，请问这个阶段一般需要几天才能最终接受，我需要做什么，谢谢。编辑会接下来与我联系吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf42097209, createdName=Jason Chan, createdTime=Sun Mar 03 00:00:00 CST 2019, time=2019-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564232, encodeId=b1d0564232d2, content=请问一下，返修后在哪里上传文件？adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待adcd 2017-06-22 10:06:00 发表: 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, beContent=adcd 2017-06-22 发表:: SCI(2016)：4.856 SCI(2015)：4.985 SCI(2014)：4.922 请问有战友大修后被拒的情况？目前返修重新审稿中，焦急等待, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/08/d21d7d20bf4243c7c8213ee2b0107192.jpg, createdBy=940a2356363, createdName=飘飘然, createdTime=Sun Dec 09 00:00:00 CST 2018, time=2018-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564110, encodeId=29d156411011, content=under review 36天了，着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cdd1681338, createdName=kikishaw, createdTime=Thu Dec 06 00:00:00 CST 2018, time=2018-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555425, encodeId=619e555425e5, content=JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=292, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Thu Apr 26 15:08:00 CST 2018, time=2018-04-26, status=1, ipAttribution=)]

2018-04-26 bigapple001

JI.JN.JBC都是被oa冲击的杂志.相对而言JI好发一点.阐明一部分机制就行.研究的当然要是热点.

292 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务